Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptor.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2006-02-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM049072HPMID 16451051PMCID PMC2528300
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of N,O-bis-Fmoc-D-Tyr-ONSu for introduction of an oxidative iodination site into cholecystokinin family peptides.

  2009cited by this paper
• Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.

  2004cited by this paper
• Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor.

  2002cited by this paper
• The Biologically Crucial C Terminus of Cholecystokinin and the Non-peptide Agonist SR-146,131 Share a Common Binding Site in the Human CCK1 Receptor

  2002cited by this paper
• Agonist-induced conformational changes in the G-protein-coupling domain of the β2 adrenergic receptor

  2001cited by this paper
• Characterization of the type A cholecystokinin receptor hormone-binding domain: use of contrasting and complementary methodologies.

  2001cited by this paper
• Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic Receptor*

  2001cited by this paper
• Crystal structure of rhodopsin: A G protein-coupled receptor.

  2000cited by this paper
• Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists.

  2000cited by this paper
• The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptor.

  2000cited by this paper
• Structurally Similar Small Molecule Photoaffinity CCK‐A Agonists and Antagonists as Novel Tools for Directly Probing 7TM Receptor—Ligand Interactions.

  1999cited by this paper
• Demonstration of a Direct Interaction between Residue 22 in the Carboxyl-terminal Half of Secretin and the Amino-terminal Tail of the Secretin Receptor Using Photoaffinity Labeling*

  1999cited by this paper
• A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.

  1999cited by this paper
• Structurally similar small molecule photoaffinity CCK-A agonists and antagonists as novel tools for directly probing 7TM receptors-ligand interactions.

  1998cited by this paper
• Direct Identification of a Second Distinct Site of Contact between Cholecystokinin and Its Receptor*

  1998cited by this paper
• Mutational analysis of the putative devazepide binding site of the CCK(A) receptor.

  1997cited by this paper
• Direct Identification of a Distinct Site of Interaction between the Carboxyl-terminal Residue of Cholecystokinin and the Type A Cholecystokinin Receptor Using Photoaffinity Labeling*

  1997cited by this paper
• Relationship Between Native and Recombinant Cholecystokinin Receptors: Role of Differential Glycosylation

  1996cited by this paper
• His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity.

  1996cited by this paper
• Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures(1).

  1996cited by this paper
• Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituent.

  1996cited by this paper
• Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures.

  1996cited by this paper
• Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger".

  1996cited by this paper
• The Role of the Cholecystokinin-B/Gastrin Receptor Transmembrane Domains in Determining Affinity for Subtype-selective Ligands(*)

  1995cited by this paper
• Backbone-dependent rotamer library for proteins. Application to side-chain prediction.

  1993cited by this paper
• Molecular cloning and functional expression of the human gallbladder cholecystokinin A receptor.

  1993cited by this paper
• Reductive Amination of Aldehydes and Ketones by Using Sodium Triacetoxyborohydride.

  1991cited by this paper
• Novel method for the rapid evaluation of packing in protein structures.

  1990cited by this paper
• Photolabeling of calmodulin with basic, amphiphilic alpha-helical peptides containing p-benzoylphenylalanine.

  1989cited by this paper
• Use of a nitrotryptophan-containing peptide for photoaffinity labeling the pancreatic cholecystokinin receptor.

  1989cited by this paper
• Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.

  1988cited by this paper
• Intrinsic photoaffinity labeling probes for cholecystokinin (CCK)-gastrin family receptors. D-Tyr-Gly-[Nle28,31,pNO2-Phe33)CCK-26-33).

  1988cited by this paper
• Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists.

  1987cited by this paper
• Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor.

  1987cited by this paper
• Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.

  1986cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• One-pot synthesis of 1,5-benzodiazepine-2,3-dicarboxylates via three-component domino reactions in the presence of γ-Fe2O3@SiO2/Ce(OTf)3

  2021cites this paper
• Crystal structure, Hirshfeld surface analysis and interaction energy and DFT studies of (S)-10-propargylpyrrolo[2,1-c][1,4]benzodiazepine-5,11-dione

  2020cites this paper
• Recyclable Itaconic Acid with Water as Green Catalytic System: Synthesis of Substituted 1,5‐Benzodiazepine Derivatives at Room Temperature

  2020cites this paper
• Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor

  2019cites this paper
• A copper(II)-mediated radical cross-dehydrogenative coupling/sulfinic acid elimination approach to 2-quinolones

  2019cites this paper
• One-pot synthesis of novel functionalized benzodiazepines via three-component or domino reactions

  2018cites this paper
• Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor.

  2016cites this paper
• The Life of Pi Star: Exploring the Exciting and Forbidden Worlds of the Benzophenone Photophore.

  2016cites this paper
• Tactical Approaches to Interconverting GPCR Agonists and Antagonists.

  2016cites this paper
• A new synthetic approach to the imidazo[1,5-a]imidazole-2-one scaffold and effective functionalization through Suzuki–Miyaura cross coupling reactions

  2016cites this paper
• Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.

  2015cites this paper
• Development of a Highly Selective Allosteric Antagonist Radioligand for the Type 1 Cholecystokinin Receptor and Elucidation of Its Molecular Basis of Binding

  2015influential citation
• A type 1 CCK receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment*

  2014cites this paper
• Synthesis of novel O-alkylbenzochromeno-1,5-benzodiazepinones. Study of the N–H····N and CO····HN hydrogen bonding interactions with 2-aminopyridines

  2014cites this paper
• A Type 1 Cholecystokinin Receptor Mutant That Mimics the Dysfunction Observed for Wild Type Receptor in a High Cholesterol Environment*

  2014cites this paper
• Environment Wild Type Receptor in a High Cholesterol That Mimics the Dysfunction Observed for A Type 1 Cholecystokinin Receptor Mutant

  2014cites this paper
• Synthesis of 5-benzyl-4-aryl-octahydro-1H-benzo[b][1,5]diazepin-2-ones as potent antidepressant and antimicrobial agents

  2014cites this paper
• One-pot microwave assisted synthesis of new 2-alkoxycarbonylmethylene-4-oxo-1,5-benzo-, naphtho-, and pyridodiazepines and assessment of their cytogenetic activity.

  2013cites this paper
• Access to Imidazo[1,2‐a]imidazolin‐2‐ones and Functionalization through Suzuki–­Miyaura Cross‐Coupling Reactions

  2013cites this paper
• Cholecystokinin Type 1 Receptor

  2013cites this paper
• Molecular Basis for Benzodiazepine Agonist Action at the Type 1 Cholecystokinin Receptor*

  2013cites this paper
• Sensitivity of cholecystokinin receptors to membrane cholesterol content

  2012cites this paper
• Appetite Control

  2012cites this paper
• Réactivité de l’acide déhydroacétique hydrogené en c5-c6 : obtention des pyrano-1,5-benzodiazépines différemment substituées et de la structure enaminone

  2012cites this paper
• Molecular Basis for Binding and Subtype Selectivity of 1,4-Benzodiazepine Antagonist Ligands of the Cholecystokinin Receptor*

  2012cites this paper
• Synthesis and Cytotoxicity Testing of New Amido-Substituted Triazolopyrrolo[2,1-c][1,4]benzodiazepine (PBDT) Derivatives

  2012cites this paper
• Microwave-assisted synthesis of medium-sized heterocycles.

  2012cites this paper
• CCK, PYY and PP: the control of energy balance.

  2012cites this paper
• In(OTf)3‐Catalyzed Synthesis of Functionalized 1,5‐Benzodiazepines from o‐Phenylenediamine and Alkyl Propiolates under Solvent‐Free Reaction Conditions

  2011cites this paper
• The Chemistry of Benzodiazepines

  2011cites this paper
• Fluorescence Polarization Screening for Allosteric Small Molecule Ligands of the Cholecystokinin Receptor

  2011cites this paper
• Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist.

  2010cites this paper
• THEMED SECTION: MOLECULAR PHARMACOLOGY OF G PROTEIN-COUPLED RECEPTORS REVIEW Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor

  2010cites this paper
• 1,5-Benzoxazepines vs 1,5-benzodiazepines. one-pot microwave-assisted synthesis and evaluation for antioxidant activity and lipid peroxidation inhibition.

  2010cites this paper
• A Novel Strategy for the Construction of Functionalized 1,5‐ Benzodiazepines via a Tandem Conjugated Addition/Cyclization Process

  2010cites this paper
• Recent progress in the application of N-halo reagents in the synthesis of heterocyclic compounds

  2010cites this paper
• Novel heterocyclic β-nitroenamines-based on a one-pot three-component reaction: a facile synthesis of fully substituted 1H-pyrrolo[1,2-a]-fused-1,3-diazaheterocycles

  2010cites this paper
• Prospective ligand- and target-based 3D QSAR: state of the art 2008.

  2009cites this paper
• Azido and Diazarinyl Analogues of Bis‐Tyrphostin as Asymmetrical Inhibitors of Dynamin GTPase

  2009cites this paper
• Click chemistry based rapid one-pot synthesis and evaluation for protease inhibition of new tetracyclic triazole fused benzodiazepine derivatives.

  2009cites this paper
• A combinatorial access to 1,5-benzodiazepine derivatives and their evaluation for aldose reductase inhibition

  2009cites this paper
• Synthesis and in vitro characterization of radioiodinatable benzodiazepines selective for type 1 and type 2 cholecystokinin receptors.

  2009cites this paper
• One-pot three-component reaction providing 1,5-benzodiazepine derivatives

  2008cites this paper
• Benzodiazepine ligands can act as allosteric modulators of the Type 1 cholecystokinin receptor.

  2008cites this paper
• Refined Docking as a Valuable Tool for Lead Optimization: Application to Histamine H3 Receptor Antagonists

  2008cites this paper
• 3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists.

  2008cites this paper
• Structural basis of cholecystokinin receptor binding and regulation.

  2008cites this paper
• Role of lysine187 within the second extracellular loop of the type A cholecystokinin receptor in agonist-induced activation. Use of complementary charge-reversal mutagenesis to define a functionally important interdomain interaction.

  2007cites this paper
• Strategies for design of non peptide CCK1R agonist/antagonist ligands.

  2007cites this paper
• Nonpeptidic ligands for peptide-activated G protein-coupled receptors.

  2007cites this paper
• Rapid approach to 3,5-disubstituted 1,4-benzodiazepines via the photo-fries rearrangement of anilides.

  2006cites this paper